Fundamentals screen · refreshed after the Sep 28, 2026 close

Net-cash companies

Companies whose cash and investments exceed all debt by at least a quarter of their market value. Net cash is cash plus short-term investments minus debt, from the latest quarterly balance sheet.

CriteriaNet cash ≥ 25% of market capMarket cap ≥ $300MCommon stock487 stocks
#CompanyPriceNet cashMkt capRevenue YoYP/E
301STBAS&T BancorpFinancials$49.11$972.6M$1.73B+0.4%12.3×
302PRKPark NationalFinancials$181.50$1.80B$3.28B+25.6%17.2×
303SNDLSundial GrowersUnclassified$1.39$186.2M$342.1M——
304VBNKVersaBankUnclassified$22.55$397.9M$731.1M——
305ALMSAlumisHealthcare$7.16$502.3M$926.8M−37.7%—
306PROKProKidneyHealthcare$1.61$181.6M$336.4M−32.1%—
307NBBKNB BancorpFinancials$22.56$533.6M$988.5M+39.5%16.7×
308KURAKura OncologyHealthcare$10.61$509.2M$943.9M+36.5%—
309RLMDRelmada TherapeuticsHealthcare$3.79$217.7M$404.3M——
310HRTGHERITAGE INSURANCE HOLDINGSFinancials$33.26$530.1M$988.9M+3.0%4.6×
311VNDAVanda PharmaceuticalsHealthcare$5.17$166.9M$312.6M−3.9%—
312OCSOculis Holding AGUnclassified$9.06$268.4M$503.1M——
313SMBCSouthern Missouri BancorpFinancials$71.50$415.7M$787.4M+2.8%11.0×
314AVIRAtea PharmaceuticalsHealthcare$5.20$219.5M$417.1M——
315MPLTMapLight TherapeuticsHealthcare$10.45$304.7M$580.8M——
316SFIXStitch FixConsumer Discretionary$2.47$172.5M$330.0M+4.2%—
317ZURAZura Bio LimitedHealthcare$4.10$205.1M$392.9M——
318ROOTRootFinancials$46.73$377.0M$724.0M+1.6%12.5×
319HGTYHagertyFinancials$13.53$783.9M$1.51B−8.7%101.1×
320ENTAEnanta PharmaceuticalsHealthcare$12.62$189.5M$367.4M−21.6%—
321BSVNBank7Financials$56.02$274.9M$533.6M−7.4%12.7×
322BNTCBenitec BiopharmaHealthcare$10.02$180.0M$349.5M——
323AURAAura BiosciencesHealthcare$6.15$323.8M$637.8M——
324ALTAltimmuneHealthcare$2.96$291.5M$575.8M−100.0%—
325JBIOJade BiosciencesHealthcare$14.35$461.2M$912.6M——
326MOHMolina HealthcareFinancials$189.64$4.96B$9.90B−4.9%—
327BFCBank FirstFinancials$151.06$836.8M$1.67B+44.1%20.6×
328MNDYmonday.comUnclassified$79.05$1.67B$3.34B——
329ZIMZIM Integrated Shipping ServicesUnclassified$28.39$1.70B$3.42B——
330FCELFuelCell Energy Inc NEW (DE)Technology$16.14$639.3M$1.29B−29.4%—
331AVTXAvalo TherapeuticsHealthcare$15.08$400.3M$808.7M——
332CTNMContineum TherapeuticsHealthcare$12.73$236.6M$478.9M——
333TECXTectonic TherapeuticHealthcare$23.51$226.9M$459.6M——
334QUBTQuantum ComputingTechnology$8.57$954.2M$1.94B+9000.0%—
335GSBCGreat Southern BancorpFinancials$77.99$415.1M$849.9M−10.5%12.6×
336PRLDPrelude Therapeutics IncorporatedHealthcare$3.91$151.8M$312.0M——
337GDYNGrid Dynamics HoldingsTechnology$7.59$298.4M$615.8M+7.0%215.1×
338SLDBSolid BiosciencesHealthcare$7.28$377.7M$780.6M——
339AKTSAktis OncologyHealthcare$19.35$517.3M$1.08B——
340ABCBAmeris BancorpFinancials$81.44$2.60B$5.47B+5.4%14.5×
341LRMRLarimar TherapeuticsHealthcare$3.17$156.3M$329.3M——
342INMDInModeUnclassified$14.21$386.2M$817.4M——
343ACNBACNBFinancials$63.18$303.4M$642.5M+4.5%11.8×
344SLDPSolid PowerIndustrials$2.26$242.4M$515.7M−103.6%—
345CAPRCapricor TherapeuticsHealthcare$8.71$237.9M$506.4M——
346RGAReinsurance Group of America, IncorporatedFinancials$252.97$7.72B$16.52B+18.5%11.0×
347ARCTArcturus Therapeutics HoldingsHealthcare$14.46$191.5M$411.0M−89.5%—
348DJCODaily JournalConsumer Discretionary$659.08$416.3M$908.2M+15.3%—
349FRVOFervo EnergyUtilities$14.11$1.88B$4.16B——
350SHAZSharonAI HoldingsTechnology$52.91$850.0M$1.89B——

Method & sources

Computed after each close from Massive / Polygon prices (split-adjusted), SEC filings, FINRA short-interest settlements and FMP earnings dates. Rows are rebuilt every session; a stock appears only when every criterion is met with current data. Full methodology

Informational screen, not a recommendation.

Net-cash companies (Sep 28) | Gainbot